# Raymond James Financial Type: Company (RJF) Source: GetYourBrief — https://getyourbrief.com/entity/raymond-james-financial Canonical HTML page: https://getyourbrief.com/entity/raymond-james-financial ## Timeline - **2026-08-22**: Wall Street Zen issues opposing ratings — Downgraded T1 Energy from Sell to Strong Sell and upgraded SM Energy from Buy to Strong Buy. - **2026-08-12**: T1 Energy earnings and BTIG target move — T1 Energy reported a -$0.09 EPS loss; BTIG raised its T1 target from $8.00 to $9.00 with a Buy rating. - **2026-08-10**: Truist raises SM Energy target — Increased price target from $37.00 to $43.00 and maintained a Buy rating. - **2026-08-05**: SM Energy quarterly results — SM Energy reported $2.19 earnings per share for the quarter. - **2026-07-21**: Two updates on SM Energy — Susquehanna lifted its SM target from $31 to $32 (Neutral); Raymond James lowered its target from $55 to $48 (Outperform). - **2026-07-14**: UBS initiates SM Energy — Started coverage with a Buy rating and a $36.00 target price. - **2026-07-08**: Weiss Ratings reaffirms T1 Energy sell — Reaffirmed a Sell (D-) rating on T1 Energy. - **2026-06-16**: Bernstein assumes T1 Energy coverage — Set a Market Perform rating and a $9.00 price objective. - **2026-06-03**: Northland Securities initiates T1 Energy — Started coverage with an Outperform rating and a $16.00 price objective. - **2026-05-20**: Zacks Research upgrades T1 Energy — Moved T1 Energy from Strong Sell to Hold. - **2026-05-14**: Siebert Williams Shank upgrades SM Energy — Raised SM Energy from Hold to Buy and lifted target price from $30.00 to $41.00. ## Recent coverage (7 stories, network-wide) ### T1 Energy Cut to Strong Sell at $4.45; SM Energy Upgraded to Strong Buy 2026-08-24 03:19:53 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Wall Street Zen issued divergent ratings on two energy names, cutting T1 Energy to Strong Sell while lifting SM Energy to Strong Buy. T1 trades at $4.45 with negative P/E and 3.5 D/E, while SM offers a 7.35 P/E and 0.85 D/E. The split highlights a rotation from leveraged loss-makers to cash-flow-positive mid-cap energy. Full story: https://getfinancebrief.com/story/t1-energy-strong-sell-sm-energy-strong-buy-wall-street-zen-2026-08 ### Northwestern Mutual Adds $125.2M in RTX and Cummins Stakes in Q2 2026-08-24 01:15:25 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2 A Q2 13F filing shows Northwestern Mutual Wealth Management initiated a $106.97M RTX position and an $18.25M Cummins stake. Analysts are raising price targets on both names, reinforcing institutional conviction in industrial cyclicals. Full story: https://getfinancebrief.com/story/northwestern-mutual-125m-rtx-cummins-13f ### ROAD Q3 Earnings Beat by $0.07, Revenue Jumps 28.2% to $999M 2026-08-12 03:18:25 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Construction Partners (ROAD) posted a $0.07 EPS surprise and 28.2% revenue growth, yet analyst downgrades and price target cuts cloud the outlook. The stock's low PEG ratio of 0.85 contrasts with a high debt load and thin margins, creating a complex picture for value and growth investors. Full story: https://getfinancebrief.com/story/road-q3-2026-earnings-beat-revenue-surge-analyst-downgrades ### Novavax Cut to Sell by Wall Street Zen as Stock Trades at $7.41 2026-08-04 12:11:39 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Wall Street Zen downgraded vaccine maker Novavax to sell, raising alarms in the healthcare sector. The stock traded at $7.41, far below its $13 consensus target, with a negative P/E of -12.78. Full story: https://gethealthbrief.com/story/novavax-sell-downgrade-wall-street-zen-health ### Wall Street Zen Slaps Sell Ratings on CME, Novavax, and SNDL – 3 Stocks to Watch 2026-08-04 12:11:28 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2 In a single day, Wall Street Zen downgraded CME Group to strong sell, and Novavax and SNDL to sell, sending bearish signals across exchanges, biotech, and cannabis. Markets digest the calls amid wide analyst disagreement. Full story: https://getfinancebrief.com/story/wall-street-zen-downgrades-cme-nvax-sndl-finance ### Biotech Sell-Off: Novavax Downgraded to Sell Despite Revenue Beat 2026-08-04 12:11:16 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Novavax was slapped with a sell rating by Wall Street Zen, even after beating Q1 revenue estimates by 49%. The downgrade highlights biotech skepticism toward small-cap vaccine players in a shifting market. Full story: https://getbiobrief.com/story/novavax-sell-downgrade-biotech-pharma ### Wall Street Sentiment Diverges Across Financials, Healthcare, and MedTech 2026-02-19 21:37:21 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 4 Analyst sentiment remains a critical barometer for Principal Financial, Raymond James, Cooper Companies, and Elevance Health as they navigate sector-specific headwinds. While wealth management and retirement services show resilience, the healthcare and medical device sectors face evolving regulatory and utilization challenges. Full story: https://getfinancebrief.com/story/wall-street-sentiment-pfg-rjf-coo-elv --- This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.